Total Payments
$4,045
2024 Payments
$1,860
Companies
24
Transactions
223
Medicare Patients
3,733
Medicare Billing
$183,211
Payment Breakdown by Category
Food & Beverage$3,849 (95.2%)
Education$195.26 (4.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,849 | 220 | 95.2% |
| Education | $195.26 | 3 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $725.59 | 59 | $0 (2024) |
| ABBVIE INC. | $573.24 | 26 | $0 (2024) |
| GENZYME CORPORATION | $400.61 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $361.74 | 21 | $0 (2024) |
| Amgen Inc. | $275.62 | 11 | $0 (2024) |
| Lilly USA, LLC | $246.25 | 23 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $237.79 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $220.31 | 7 | $0 (2024) |
| PFIZER INC. | $181.67 | 10 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $161.06 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,860 | 93 | ABBVIE INC. ($425.97) |
| 2023 | $1,218 | 67 | Janssen Biotech, Inc. ($191.92) |
| 2022 | $459.11 | 45 | Janssen Biotech, Inc. ($212.47) |
| 2021 | $507.43 | 18 | Ortho Dermatologics, a division of Bausch Health US, LLC ($146.89) |
All Payment Transactions
223 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Immunology | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Immunology | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Inflammation | ||||||
| 10/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.24 | General |
| 09/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Dermatology | ||||||
| 09/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: DERMATOLOGY | ||||||
| 08/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Immunology | ||||||
| 08/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $2.41 | General |
| Category: Immunology | ||||||
| 07/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.10 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Inflammation | ||||||
| 07/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 479 | 879 | $50,060 | $17,896 |
| 2022 | 14 | 1,059 | 1,895 | $127,632 | $55,502 |
| 2021 | 15 | 1,134 | 2,007 | $138,651 | $62,840 |
| 2020 | 13 | 1,061 | 1,880 | $156,346 | $46,973 |
Total Patients
3,733
Total Services
6,661
Medicare Billing
$183,211
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 117 | 130 | $13,217 | $4,561 | 34.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 52 | 55 | $6,851 | $2,889 | 42.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 101 | 117 | $8,702 | $2,722 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 54 | $7,800 | $2,525 | 32.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 40 | 44 | $4,908 | $1,601 | 32.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 80 | 435 | $3,176 | $1,499 | 47.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 14 | 15 | $2,806 | $1,043 | 37.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $1,767 | $613.93 | 34.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 13 | 15 | $833.40 | $442.24 | 53.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 217 | 280 | $29,227 | $12,640 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 149 | $22,199 | $10,137 | 45.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 119 | 137 | $18,106 | $7,679 | 42.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 188 | 243 | $17,140 | $6,910 | 40.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 93 | 103 | $11,204 | $5,313 | 47.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $7,896 | $3,138 | 39.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 137 | 791 | $6,745 | $2,899 | 43.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 49 | 49 | $6,153 | $2,513 | 40.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 23 | 28 | $4,831 | $2,381 | 49.3% |
| 10040 | Acne surgery | Office | 2022 | 11 | 11 | $1,339 | $710.34 | 53.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 15 | 18 | $974.86 | $446.46 | 45.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 15 | $907.18 | $377.28 | 41.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 14 | 14 | $853.48 | $342.99 | 40.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 14 | 17 | $57.24 | $13.92 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 208 | 258 | $26,967 | $12,042 | 44.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 136 | 165 | $24,321 | $11,175 | 45.9% |
About Samantha Stratton, P.A-C
Samantha Stratton, P.A-C is a Physician Assistant healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2012. The National Provider Identifier (NPI) number assigned to this provider is 1336413095.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Samantha Stratton, P.A-C has received a total of $4,045 in payments from pharmaceutical and medical device companies, with $1,860 received in 2024. These payments were reported across 223 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,849).
As a Medicare-enrolled provider, Stratton has provided services to 3,733 Medicare beneficiaries, totaling 6,661 services with total Medicare billing of $183,211. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Lexington, KY
- Active Since 02/28/2012
- Last Updated 05/01/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1336413095
Products in Payments
- TREMFYA (Drug) $701.94
- DUPIXENT (Biological) $620.92
- RINVOQ (Biological) $351.92
- Otezla (Drug) $275.62
- TALTZ (Drug) $246.25
- COSENTYX (Drug) $220.62
- SKYRIZI (Biological) $193.82
- EUCRISA (Drug) $166.40
- DUOBRII (Drug) $146.89
- ADBRY (Biological) $136.72
- ILUMYA (Biological) $91.60
- Absorica LD (Drug) $78.58
- COSENTYX (Biological) $73.87
- Winlevi (Drug) $67.61
- Bimzelx (Biological) $64.96
- Erivedge (Biological) $63.84
- VTAMA (Drug) $57.33
- OPZELURA (Drug) $54.40
- Seysara (Drug) $31.82
- INNOVAMATRIX AC (Device) $30.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Lexington
Ms. Lauren Meade, Pa-C, PA-C
Physician Assistant — Payments: $586,865
Physician Assistant $586,865
Brandice Harrison, Pa-C, PA-C
Physician Assistant — Payments: $581,472
Physician Assistant $581,472
Amber Erwin, Pa-C, PA-C
Physician Assistant — Payments: $11,278
Physician Assistant $11,278
Mr. Edwin Robbins, Pa-C, PA-C
Physician Assistant — Payments: $9,751
Physician Assistant $9,751
Vedrana Knezevic, Pa-C, PA-C
Physician Assistant — Payments: $9,611
Physician Assistant $9,611
Sarah Dougherty, Pa-C, PA-C
Physician Assistant — Payments: $7,472
Physician Assistant $7,472